Category Uncategorized

COVID-19 – infection prevention and control literature – December 2020

Originally posted on Microbiology and Infectious Diseases postgraduate teaching (PRIDA):
Papers that related to COVID-19 infection prevention and control from the daily?COVID-19?Critical Intelligence Unit? listings and other identified literature.? This posting does not assess the specific evidence or its quality. Please let me know of any significant gaps – @mdjkf?. Peer reviewed journals Meta-analysis: Effectiveness…

REVIVE Antimicrobial Encyclopaedia

Originally posted on Microbiology and Infectious Diseases postgraduate teaching (PRIDA):
The Global Antibiotic Research & Development Partnership (GARDP) has announced the launch of their new resource, the Encyclopaedia – REVIVE (gardp.org). A great new resource!    This resource includes definitions of terms from the field of antimicrobials including ‘Active Pharmaceutical Ingredient’, ‘Bacterial efflux’ and ‘Minimum…

COVID-19 – recent infection prevention and control literature – October 2020

Updates weekly – COVID19 – new infection control evidence

Essential clinical care of Staphylococcus aureus bloodstream infection (SAB)

Originally posted on AIMED – Let's talk about antibiotics:
Updated 8/5/20. A. Healthcare-associated events (2018, HNE LHD ) 60 healthcare-associated SAB cases occurred with 7% due to methicillin-resistant Staphylococcus aureus (MRSA) and age-adjusted 30 day mortality of 9%. SAB relapse within 15-90 days occurred in 2.1% of adult events 7% of paediatric events. Principle…

Inducing ceftriaxone-deficiency in hospitals: practical stewardship insights

Originally posted on AIMED – Let's talk about antibiotics:
2018 update! Just as relevant. Upside – Ceftriaxone and cefotaxime (third generation cephalosporins-TGC) are amongst the most important agents for directed therapy of infections due to Gram negative organisms that are resistant to ampicillin or cephazolin (a first generation cephalosporin),  including Klebsiella pneumoniae .  They penetrate the CSF…